Dela Cruz, Glaiza G.
HRN: 13-02-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/09/2024
CEFUROXIME 500MG (TAB)
02/09/2024
02/16/2024
ORAL
500mg
2x/day
S/p Primary LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes